Perrigo is uniquely positioned as the only global company with a mix of generic over-the-counter and prescription pharmaceuticals, nutritional products, and active pharmaceutical ingredients, delivering value by meeting the growing need for "Quality Affordable Healthcare Products®."

FY15 - Recast Exhibits can be found here.

print email rss
Price Data
Key Contacts
Arthur J. Shannon
Vice President, Investor Relations and Communication
269-686-1709 (direct)
269-673-9128 (fax)
Brad Joseph
Director, Investor Relations and Communication
269-686-3373 (direct)
269-673-9128 (fax)

Subscribe to News Alerts